It has incomplete penetrance, which is also dependent on which MMR gene is affected, but most individuals with Lynch syndrome face much higher risks of colorectal cancer, endometrial cancer, and ovarian cancer than the general population [1]. This evidence concerns the gene MRC1 and Lynch syndrome.